(Q36364527)

13 August 2017

1 reference

title

Update on the molecular biology of mantle cell lymphoma (English)

1 reference

13 August 2017

0 references

4

Franco Cavalli

1 reference

13 August 2017

Francesco Bertoni

1

1 reference

13 August 2017

Andrea Rinaldi

series ordinal

2

1 reference

13 August 2017

Emanuele Zucca

series ordinal

3

1 reference

13 August 2017

publication date

1 March 2006

1 reference

13 August 2017

published in

Hematological Oncology

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

22-27

1 reference

13 August 2017

1 reference

7 January 2021

Mantle cell lymphoma: at last, some hope for successful innovative treatment strategies

1 reference

7 January 2021

Current treatment approaches for mantle-cell lymphoma

1 reference

7 January 2021

The immune system. First of two parts

1 reference

7 January 2021

CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans

1 reference

7 January 2021

Cellular origin of human B-cell lymphomas.

1 reference

7 January 2021

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease

1 reference

7 January 2021

Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

1 reference

7 January 2021

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma

1 reference

7 January 2021

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.

1 reference

7 January 2021

Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research

1 reference

7 January 2021

IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome

1 reference

7 January 2021

Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis

1 reference

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

7 January 2021

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

1 reference

7 January 2021

Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes

1 reference

7 January 2021

Molecular basis of mantle cell lymphoma

1 reference

7 January 2021

Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways

1 reference

7 January 2021

Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.

1 reference

7 January 2021

Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector

1 reference

7 January 2021

Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis

1 reference

7 January 2021

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb.

1 reference

7 January 2021

CDK4andMDM2Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-typeINK4a/ARFLocus

1 reference

7 January 2021

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

7 January 2021

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

1 reference

7 January 2021

Mantle cell lymphoma is characterized by inactivation of the ATM gene

1 reference

7 January 2021

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma

1 reference

7 January 2021

CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas

1 reference

7 January 2021

Mutations of Chk2 in primary hematopoietic neoplasms

1 reference

7 January 2021

Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms

1 reference

7 January 2021

Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

7 January 2021

In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas.

1 reference

7 January 2021

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

1 reference

7 January 2021

Targeting histones and proteasomes: new strategies for the treatment of lymphoma

1 reference

7 January 2021

Oncogenes as molecular targets in lymphoma

1 reference

7 January 2021

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma

1 reference

7 January 2021

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

1 reference

7 January 2021

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

1 reference

7 January 2021

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

1 reference

7 January 2021

High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma

1 reference

7 January 2021

Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization

1 reference

7 January 2021

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

1 reference

7 January 2021

Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.

1 reference

7 January 2021

Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays

1 reference

7 January 2021

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line

1 reference

7 January 2021

Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.767

1 reference

13 August 2017

1 reference